Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 22, 2023
Ganetespib (STA-9090) augments sorafenib efficacy via necroptosis induction in hepatocellular carcinoma: Implications from preclinical data for a novel therapeutic approachSameh Saber, Alexandru Madalin Hasan, Osama A Mohammed, et al.
International Journal of Molecular Sciences|July 15, 2026
Natural Products in Prostate Cancer: Crosstalk Among the Gut Microbiome, Androgen Receptor Signaling, and Epigenetic RegulationMohammad Muzaffar Mir, Javed Iqbal Wani, Rashid Mir, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 28, 2024
Emerging insights into the role of natural products and miRNAs in psoriasis: from pathophysiology to precision medicineOsama A Mohammed, Mushabab Alghamdi, Emad Bahashwan, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
(R,R)-BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and PyroptosisSameh Saber, Mohannad Mohammad S Alamri, Jaber Alfaifi, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953Sameh Saber, Mohannad Mohammad S Alamri, Jaber Alfaifi, et al.
Frontiers in Pharmacology|October 16, 2023
Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosisRasha Abdelhady, Sameh Saber, Mustafa Ahmed Abdel-Reheim, et al.
Frontiers in Pharmacology|March 28, 2024
Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosisRasha Abdelhady, Sameh Saber, Mustafa Ahmed Abdel-Reheim, et al.
Pathology, Research and Practice|January 6, 2024
The emerging role of miRNAs in myocardial infarction: From molecular signatures to therapeutic targetsOsama A Mohammed, Mushabab Alghamdi, Jaber Alfaifi, et al.
International Journal of Biological Macromolecules|April 27, 2024
miRNAs dysregulation in ankylosing spondylitis: A review of implications for disease mechanisms, and diagnostic markersOsama A Mohammed, Mushabab Alghamdi, Masoud I E Adam, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo InvestigationsOsama A Mohammed, Mustafa Ahmed Abdel-Reheim, Mohannad Mohammad S Alamri, et al.
Pageof 3